Eponemycin

N/A

Report date: 2023/02/18 16:53:00

Base Information

Drug NameEponemycin
Drug Alias NameBU-3862TBMY-28647
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionAngiogenesis inhibitorsProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A